Methylenedioxydimethylamphetamine

Psychoactive drug of the amphetamine class

Methylenedioxydimethylamphetamine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Methylenedioxydimethylamphetamine (MDDM) is a synthetic psychoactive drug belonging to the amphetamine class. It is structurally related to methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA), both of which are well-known for their stimulant and empathogenic effects. MDDM is less commonly encountered than its analogs and has been the subject of limited scientific research.

Chemical Structure and Properties

MDDM is characterized by the presence of a methylenedioxy group attached to the phenyl ring of the amphetamine structure. This modification is similar to that found in MDMA, contributing to its psychoactive properties. The chemical formula of MDDM is C11H15NO2, and it has a molecular weight of 193.25 g/mol.

Pharmacology

MDDM acts primarily as a serotonin and dopamine releasing agent, similar to other methylenedioxy-substituted amphetamines. This action is responsible for its psychoactive effects, which include increased energy, euphoria, and altered sensory perception. The exact mechanism of action involves the release of neurotransmitters from presynaptic neurons and inhibition of their reuptake.

Effects

The effects of MDDM are reported to be similar to those of MDMA, though potentially less potent. Users may experience heightened mood, increased sociability, and enhanced sensory perception. However, due to its limited use and research, the full spectrum of effects and potential risks are not well-documented.

Legal Status

MDDM is not as widely regulated as MDMA, but it may fall under analog drug laws in certain jurisdictions, which control substances based on their structural similarity to controlled drugs. The legal status of MDDM can vary significantly between countries and regions.

Synthesis

The synthesis of MDDM involves the reaction of safrole or isosafrole with a suitable amine, followed by reductive amination. This process is similar to the synthesis of other methylenedioxy-substituted amphetamines. Due to its potential for misuse, the synthesis of MDDM is typically restricted to licensed laboratories.

Potential Risks and Side Effects

As with other psychoactive substances, the use of MDDM carries potential risks, including neurotoxicity, cardiovascular effects, and psychological dependence. The lack of comprehensive studies on MDDM means that its safety profile is not well understood, and caution is advised for any experimental use.

Related Compounds

• Methylenedioxyamphetamine (MDA)
• Methylenedioxymethamphetamine (MDMA)
• Amphetamine
• Phenethylamine

Related Pages

• Psychoactive drug
• Serotonin releasing agent
• Dopamine releasing agent